MOONLAKE IMMUNOTHERAPEUTICS (MLTX) Stock Cash Flow
NASDAQ:MLTX • KY61559X1045
Current stock price
17.75 USD
-0.27 (-1.5%)
At close:
17.64 USD
-0.11 (-0.62%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -230.32M | -121.24M | -44.08M | -64.51M | -53.64M | |||
| Depreciation Amortization | 2.62M | 1.38M | 13.20K | 10.00K | 0.00 | |||
| Change In Working Capital | 19.88M | -3.78M | -6.22M | -1.43M | 4.48M | |||
| Interest Paid | 5.06M | N/A | N/A | N/A | N/A | |||
| Taxes Paid | 799.00K | 147.30K | 41.70K | N/A | N/A | |||
| Other non cash items | 11.82M | 7.06M | 7.51M | 10.03M | 13.98M | |||
| OPERATING CASH FLOW | -196.01M | -116.59M | -42.78M | -55.89M | -35.18M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -35.00K | -519.50K | -284.60K | -20.00K | -50.00K | |||
| Other Investing Activity | 203.03M | -205.08M | -24.90M | -32.32M | N/A | |||
| INVESTING CASH FLOW | 202.99M | -205.60M | -25.18M | -32.34M | -50.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 72.39M | N/A | 0.00 | -15.00M | 15.00M | |||
| Stock Issued/Repurchased | 73.60M | 52.78M | 482.45M | 50.00K | 28.26M | |||
| Other Financing Activity | 0.00 | -1.47M | -2.75M | 134.65M | 0.00 | |||
| FINANCING CASH FLOW | 146.00M | 51.31M | 479.70M | 119.69M | 43.26M | |||
| Exchange Rate Effect | 1.11M | 128.00K | -75.30K | 10.00K | 0.00 | |||
| CHANGE IN CASH | 154.09M | -270.74M | 411.66M | 31.47M | 8.03M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -196.01M | -116.59M | -42.78M | -55.89M | -35.18M | |||
| Capital Expenditure | -35.00K | -519.50K | -284.60K | -20.00K | -50.00K | |||
| FREE CASH FLOW | -196.04M | -117.11M | -43.06M | -55.91M | -35.23M | |||
All data in USD